Raghavan Murugan

About

Dr. Murugan is a Professor of Critical Care Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine, where he also serves as Chief of Critical Care Medicine and the Medical Director of the Adult Medical Surgical ICU at UPMC Magee Womens Hospital. He is the Program Director for Critical Care Nephrology within CRISMA.

Dr. Murugan has practiced academic critical care medicine for 18 years and is licensed in the USA, UK, and India. He has a Master’s Degree in clinical research with a focus on clinical trials from the University of Pittsburgh. A Fellow of the American College of Critical Care Medicine (FCCM) and the Royal College of Physicians (FRCP), United Kingdom, Dr. Murugan has authored more than 160 publications and a textbook.

With an extensive global network in intensive care medicine, Dr. Murugan has dedicated his research career to observational studies and interventional clinical trials focused on preventing and treating acute kidney injury. His research, funded by the National Institutes of Health and industry partners, has been published in leading journals such as the New England Journal of Medicine, JAMA, Kidney International, and Critical Care Medicine. A recipient of funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Dr. Murugan has served the Society of Critical Care Medicine (SCCM) for 20 years and is committed to improving the care of critically ill patients and reducing morbidity and mortality.

Employment

• University of Pittsburgh Professor
  2006 - Present
• University of Pittsburgh

Education

• University of Pittsburgh School of Medicine MS
  2006 - 2008
• Stanley Medical College MBBS
  1991 - 1995
• Dakshin Bharat Hindi Prachar Sabha BA
  1988 - 1991

Projects & Funding

Projects & funding information is unavailable.

Publications (101)

• Alternative net ultrafiltration rate strategies in acute kidney injury: a feasibility randomized clinical trial
  Critical Care 2026 DOI: 10.1186/s13054-026-06040-7
  +Save
• Feasibility and acceptability of weight-based net fluid removal during continuous kidney replacement therapy: A nursing survey
  Applied Nursing Research 2026 DOI: 10.1016/j.apnr.2026.152066
  +Save
• Predicting Acute Kidney Injury with Nephrotoxic Burden in Noncritical Patients
  Kidney360 2026 DOI: 10.34067/KID.0000000998
  +Save
• Protocolized fluid balance neutralization during continuous renal replacement therapy
  Intensive Care Medicine 2024 DOI: 10.1007/s00134-024-07698-9
  +Save
• Contrast-associated acute kidney injury and cardiovascular events: a secondary analysis of the PRESERVE cohort
  Clinical Kidney Journal 2023 DOI: 10.1093/ckj/sfad214
  +Save
• Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
  Intensive Care Medicine Experimental 2023 DOI: 10.1186/s40635-023-00566-8
  +Save
• A deep learning–based dynamic model for predicting acute kidney injury risk severity in postoperative patients
  Surgery 2023 DOI: 10.1016/j.surg.2023.05.003
  +Save
• Restrictive versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI): a pilot clinical trial protocol
  BMJ Open 2023 DOI: 10.1136/bmjopen-2023-075960
  +Save
• Kidney Cell Cycle Arrest and Cardiac Biomarkers and Acute Kidney Injury Following Angiography: The Prevention of Serious Adverse Events Following Angiography (PRESERVE) Study
  Kidney Medicine 2023 DOI: 10.1016/j.xkme.2022.100592
  +Save
• Case presentations of medication management for patients at risk for drug-associated acute kidney injury identified with a CDS system and a novel biomarker
  American Journal of Health-System Pharmacy 2023 DOI: 10.1093/AJHP/ZXAC322
  +Save